TC
TAP Consulting’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.46M | Buy |
10,562
+486
| +5% | +$159K | 0.71% | 39 |
|
|
2024
Q3 | $3.02M | Buy |
10,076
+2,407
| +31% | +$722K | 0.6% | 51 |
|
|
2024
Q2 | $2.53M | Sell |
7,669
-153
| -2% | -$50.4K | 0.53% | 56 |
|
|
2024
Q1 | $3.1M | Buy |
7,822
+1,325
| +20% | +$524K | 0.68% | 38 |
|
|
2023
Q4 | $2.29M | Sell |
6,497
-74
| -1% | -$26.1K | 0.55% | 46 |
|
|
2023
Q3 | $2.47M | Sell |
6,571
-1,732
| -21% | -$650K | 0.63% | 45 |
|
|
2023
Q2 | $3.18M | Sell |
8,303
-1,519
| -15% | -$581K | 0.78% | 36 |
|
|
2023
Q1 | $3.4M | Sell |
9,822
-2,010
| -17% | -$696K | 0.83% | 35 |
|
|
2022
Q4 | $2.78M | Sell |
11,832
-1,082
| -8% | -$255K | 0.73% | 40 |
|
|
2022
Q3 | $3.18M | Buy |
12,914
+744
| +6% | +$183K | 0.85% | 33 |
|
|
2022
Q2 | $3.68M | Sell |
12,170
-4,409
| -27% | -$1.33M | 1.02% | 32 |
|
|
2022
Q1 | $6.81M | Buy |
16,579
+1,535
| +10% | +$630K | 1.78% | 19 |
|
|
2021
Q4 | $7.06M | Buy |
15,044
+651
| +5% | +$305K | 1.61% | 22 |
|
|
2021
Q3 | $6.11M | Sell |
14,393
-925
| -6% | -$393K | 1.64% | 19 |
|
|
2021
Q2 | $5.5M | Buy |
15,318
+288
| +2% | +$103K | 1.54% | 21 |
|
|
2021
Q1 | $4.24M | Buy |
15,030
+161
| +1% | +$45.4K | 1.31% | 25 |
|
|
2020
Q4 | $4.21M | Sell |
14,869
-1,592
| -10% | -$451K | 1.52% | 20 |
|
|
2020
Q3 | $4.53M | Sell |
16,461
-2,043
| -11% | -$562K | 1.78% | 18 |
|
|
2020
Q2 | $4.2M | Sell |
18,504
-2,053
| -10% | -$466K | 2.07% | 13 |
|
|
2020
Q1 | $3.13M | Buy |
20,557
+1,069
| +5% | +$163K | 2.11% | 14 |
|
|
2019
Q4 | $2.93M | Buy |
19,488
+1,576
| +9% | +$237K | 1.63% | 19 |
|
|
2019
Q3 | $2.54M | Buy |
+17,912
| New | +$2.54M | 1.5% | 22 |
|
|
2019
Q1 | $1.87M | Buy |
+16,960
| New | +$1.87M | 1.41% | 25 |
|